Blog

Filter by

Celebrating Partnership: EUROIMMUN Neuroimmunology Summit May 5, 2022

Thank you EUROIMMUN for inviting the AE Alliance family to attend the EUROIMMUN Neuroimmunology Summit. All AE Alliance Clinicians and Support Network members are invited to attend this one-day virtual summit bringing together neurologic medical experts from across the United States. The topics to be discussed include: Updated guidelines for the diagnosis of neuroimmunology conditions […]

Why Research Network Month? A Conversation with Caterri Woodrum & Meg Poe May 4, 2022

The Research Network launched in May, 2020 and resulted in the first AEA Community Seed Grant Program in 2021. This program supports research focused on the diagnosis, management, and outcomes of individuals with AE. The program is funded by members, friends and supporters of the AE Alliance Community. Would you like to know the answers […]

May is AEA Research Network Month: What is it? May 2, 2022

AEA Research Network Month is when the AE Alliance focuses on research funding, collaborations and AE research awareness. What’s our goal? Raise funds for the 2023 Seed Grant Program. Provide you, the AEA Community a strong understanding of the huge importance of research and AE. What can you expect during May 2022? A better understanding […]

Florence Forth Virtual: How Does A First-Timer Celebrate Heroes? February 15, 2022

Thank you Meg for sharing your plans for Florence Forth Virtual and In-Person! Are you still unsure how to create your Florence Forth Virtual Event? Our new Director of Patient Support, Programs and Administration focuses on the event everyday. We asked her a few questions and found out how she’s celebrating her heroes this year. […]

Research Opportunity: Living with LGI1? Share Your Experience February 11, 2022

If you are diagnosed with LGI1 autoimmune encephalitis (LGI1) or are the caregiver of someone with LGI1, you may qualify to participate in this study conducted by Fulcrum Research Group. The goal of the study is to better understand the patient experience with LGI1 autoimmune encephalitis for the purpose of supporting potential treatments and potentially […]

Florence Forth Virtual: A How To From The Experts! #3 February 8, 2022

Thank you Lisa and Jackie for sharing your 2021 Florence Forth Virtual experiences on social media after the event and for providing expert tips for this year. What makes someone an expert? They’ve done it! The Florence Forth Virtual Event is an opportunity for you to get involved, celebrate your heroes, raise funds and awareness […]

Florence Forth Virtual: A How To From The Experts! #2 February 1, 2022

Thank you Rachael for sharing your 2021 Florence Forth Virtual experience! We decided the best way for you to understand what it means to participate in the Florence Forth Virtual event is to ask the experts. What makes someone an expert? They’ve done it! Q1 What did you enjoy about the 2021 Virtual Florence Forth […]

Florence Forth Virtual: A How To From The Experts! #1 January 27, 2022

Thank you Team Fledderjohn for sharing your 2021 Florence Forth Virtual experience! We decided the best way for you to understand what it means to participate in the Florence Forth Virtual event is to ask the experts. What makes someone an expert? They’ve done it! Q1 What did you enjoy about the 2021 Virtual Florence […]

2022 AEA Community Seed Grant Program is now open! January 21, 2022

Funded by the Autoimmune Encephalitis Alliance, Inc. (AE Alliance) IMPORTANT DATES Application Deadline: May 2, 2022 Award Notification: Early June 2022 The AE Alliance is pleased to announce the call for applications to our second annual AEA Community Seed grant program to support research focused on the diagnosis, management, and outcomes of individuals with autoimmune […]

BREAKING NEWS: The ExTINGUISH trial will start recruitment in January 2022! December 1, 2021

We are excited to report that the ExTINGUISH Trial will start recruitment in January 2022. This trial is a Phase-2b, Double-Blind, Randomized Controlled Trial to Evaluate the Activity and Safety of Inebilizumab in Anti-NMDA Receptor (NMDAR) Encephalitis and Assess Markers of Disease. This trial is the result of the dedication and hard work of Dr. […]